| scholarly article | Q13442814 |
| P50 | author | Alma Zernecke | Q21253006 |
| Elisa Anamaria Liehn | Q30347994 | ||
| Christian Weber | Q37838769 | ||
| Ilze Bot | Q41611730 | ||
| Ute Raffetseder | Q58825670 | ||
| Erdenechimeg Shagdarsuren | Q66472623 | ||
| P2093 | author name string | Regina Krohn | |
| Peter R. Mertens | |||
| Erik A. Biessen | |||
| Peter J. Nelson | |||
| Peter J. van Santbrink | |||
| P2860 | cites work | Functional macrophage cell lines transformed by abelson leukemia virus | Q40177539 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1812–1820 | |
| P577 | publication date | 2007-10-16 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice | |
| P478 | volume | 116 |
| Q89819876 | Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis |
| Q88089822 | Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock |
| Q49644763 | CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. |
| Q33985284 | Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation |
| Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
| Q34430115 | Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes |
| Q37652971 | Chemokines in the vascular inflammatory response of atherosclerosis |
| Q58695185 | Cold shock proteins: from cellular mechanisms to pathophysiology and disease |
| Q35640438 | Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. |
| Q35555437 | Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects |
| Q63915166 | Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1 |
| Q37723178 | Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases |
| Q33496141 | Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome |
| Q55402211 | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma. |
| Q36537470 | Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study |
| Q33722663 | Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response |
| Q24634312 | JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? |
| Q34457225 | MCP-1 contributes to arteriovenous fistula failure |
| Q35323782 | Myocardin regulates vascular smooth muscle cell inflammatory activation and disease |
| Q35865871 | PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis |
| Q34146505 | Regulation of CCL5 expression in smooth muscle cells following arterial injury |
| Q27003124 | Regulation of atherogenesis by chemokines and chemokine receptors |
| Q36353087 | Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan |
| Q35879518 | Retinoic acid receptor α mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells. |
| Q37704741 | Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease |
| Q90481574 | Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice |
| Q37189621 | Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor κB activation |
| Q33559676 | Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice |
| Q38148785 | Targeting CCL5 in inflammation |
| Q36990311 | The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition |
| Q38190448 | The role of cold shock domain proteins in inflammatory diseases |
| Q37663856 | Vitamin D and cardiovascular risk |
| Q36197071 | Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells |
| Q39819288 | YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation |
| Q38700854 | YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation |
| Q38065264 | YB-1: oncoprotein, prognostic marker and therapeutic target? |
Search more.